Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis

• Auteurs principaux: Nabila Ferahta (Auteur), Lukshe Kanagaratnam (Auteur), Moustapha Dramé (Auteur), Thomas Vogel (Auteur), Pierre-Jacques Ambrosi (Auteur), Pierre-Olivier Lang (Auteur)
• Format: Livre
• Publié: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2017-07-10.
• Sujets: Research Article
• Accès en ligne: Connect to this object online.

<p><strong>Background: </strong>Randomized trials have shown that oral direct factor Xa inhibitors (ODIXa) offer potential advantages over vitamin K antagonists (VKAs). It is however unclear whether the magnitude of their benefi t is similar at the current recommended doses.</p&...